Correction: Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncted Abeta in sporadic Alzheimer disease cases and mouse models
Acta Neuropathol. 2024 Mar 25;147(1):59.
doi: 10.1007/s00401-024-02718-w.
1 University Medical Center Göttingen, Department of Psychiatry and Psychotherapy, Division of Molecular Psychiatry, Göttingen, Germany.
2 ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, VIC, 3065, Australia.
3 Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC, Australia.
4 University Medical Center Göttingen, Department of Psychiatry and Psychotherapy, Göttingen, Germany.
5 University Medical Center Göttingen, Department of Psychiatry and Psychotherapy, Division of Molecular Psychiatry, Göttingen, Germany. [email protected].